SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-18-020106
Filing Date
2018-07-18
Accepted
2018-07-18 17:35:30
Documents
2
Period of Report
2018-07-18

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 14814
2 EX-24.1 DOCUMENT attachment1.htm EX-24.1 3514
  Complete submission text file 0000899243-18-020106.txt   19729
Mailing Address 215 FIRST STREET SUITE 200 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 200 CAMBRIDGE MA 02142 617-714-0555
CONSTELLATION PHARMACEUTICALS INC (Issuer) CIK: 0001434418 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O IMMUNE DESIGN CORP. 1616 EASTLAKE AVE. E, SUITE 310 SEATTLE WA 98102
Business Address
Svennilson Peter (Reporting) CIK: 0001606074 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38584 | Film No.: 18959101